Michael L Levitz Anika Therapeutics, Inc. (ANIK) insider trading activity

Michael L Levitz is EVP, CFO, Treasurer of Anika Therapeutics, Inc.. Currently has a direct ownership of 46,955 shares of ANIK, which is worth approximately $824,060. The most recent transaction as insider was on Mar 11, 2024, when has been sold 5,638 shares (Common Stock) at a price of $25.54 per share, resulting in proceeds of $143,994. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47K

0% 3M change

41.29% 12M change

Total Value Held $824,060

Michael L Levitz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Payment of exercise price or tax liability	$143,994 $25.54 p/Share	5,638 Reduced 10.72%	46,955 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	19,201 Added 27.92%	49,565 Common Stock
Aug 10 2023	SELL Payment of exercise price or tax liability	$21,051 $18.58 p/Share	1,133 Reduced 3.3%	33,232 Common Stock
Aug 10 2023	BUY Exercise of conversion of derivative security	-	3,859 Added 10.1%	34,365 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$68,094 $26.1 p/Share	2,609 Reduced 8.04%	29,838 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	8,888 Added 21.5%	32,447 Common Stock
Mar 09 2023	SELL Payment of exercise price or tax liability	$35,063 $26.91 p/Share	1,303 Reduced 5.24%	23,559 Common Stock
Mar 09 2023	BUY Exercise of conversion of derivative security	-	4,439 Added 15.15%	24,862 Common Stock
Aug 10 2022	BUY Exercise of conversion of derivative security	-	3,859 Added 15.89%	20,423 Common Stock
Mar 11 2022	BUY Open market or private purchase	$98,480 $24.62 p/Share	4,000 Added 20.08%	15,924 Common Stock
Mar 09 2022	BUY Exercise of conversion of derivative security	-	4,438 Added 27.12%	11,924 Common Stock
Aug 12 2021	BUY Open market or private purchase	$31,235 $40.2 p/Share	777 Added 9.4%	7,486 Common Stock
Aug 11 2021	BUY Open market or private purchase	$114,598 $40.21 p/Share	2,850 Added 29.81%	6,709 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	-	3,859 Added 50.0%	3,859 Common Stock

MLL

Michael L Levitz

EVP, CFO, Treasurer

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Value

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Anika Therapeutics, Inc.

Track Activities on ANIK

Account